Stay updated on Talimogene Laherparepvec & Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Talimogene Laherparepvec & Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Talimogene Laherparepvec & Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The webpage has updated its date listings, removing older dates and adding new ones for May 2025.
    Difference
    0.4%
    Check dated 2025-05-08T13:50:33.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T06:14:31.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The webpage has added new dates, specifically April 8 and April 20 of 2025, and introduced a new biosimilar product, Pembrolizumab Biosimilar SB27. The previous dates of December 3 and December 27, 2024, have been removed.
    Difference
    0.6%
    Check dated 2025-04-23T23:34:25.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the removal of detailed descriptions of a phase II clinical trial for advanced melanoma treatments and the addition of new identifiers and revisions related to the study. The principal investigator's name has also been updated.
    Difference
    46%
    Check dated 2025-04-16T20:23:53.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to December 27, 2024.
    Difference
    0.4%
    Check dated 2025-04-09T13:25:28.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous estimated update date of December 27, 2024, and revision version 2.14.2.
    Difference
    0.2%
    Check dated 2025-04-02T00:07:57.000Z thumbnail image

Stay in the know with updates to Talimogene Laherparepvec & Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Talimogene Laherparepvec & Pembrolizumab in Melanoma Clinical Trial page.